Study S002149

A Phase IV, Randomized Controlled Trial to Evaluate the Effects of Resistance Training Versus Usual Care on Thigh Muscle Volume During Treatment With the Dual GIP/GLP-1 Receptor Agonist Tirzepatide in Adults With Obesity

ClinicalTrials.gov record

Registration

Registration: NCT07777575
Acronym: RESIST
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: DOUBLE
Status: RECRUITING
Enrollment: 150
Start: 2026-09-07
Primary completion: 2027-05-31
Lead sponsor: Technical University of Munich
Conditions: Obesity (BMI>30)
Interventions: DRUG:Dual GIP/GLP-1 Receptor Agonist Tirzepatide; BEHAVIORAL:Resistance Training
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: CTIS:2026-526200-69-00

Registered primary outcomes

Change in contractile thigh muscle volume (mL), as assessed by magnetic resonance imaging (MRI) [From baseline to the end of treatment at 24 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.